Historical record - last NADAC effective date: 11/20/2019
Product Information
BUPROPION HCL SR 100 MG TABLET is a generic product labeled by Dr. Reddy's Laboratories Inc., priced at $0.1660 per EA under NDC 43598053601. Its NADAC has been published 159 times since Nov 23, 2016.
FDA first approved this application on Mar 1, 2016. Its Orange Book therapeutic-equivalence code is AB1 — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
100 mg/1
Manufacturer
Dr. Reddy's Laboratories Inc.NDC
43598053601
Classification
Generic
Dosage Form
TABLET, FILM COATED, EXTENDED RELEASE
Route
ORAL
Effective Date
11/20/2019
Active Ingredients
BUPROPION HYDROCHLORIDEApproval Type
Generic (ANDA)
FDA Application
ANDA205794FDA Approved
3/1/2016
TE Code
AB1
On Market Since
8/1/2016
Pharmacological Classes
Price Statistics
The NADAC for BUPROPION HCL SR 100 MG TABLET has been published 159 times since Nov 23, 2016, and over the history we have for it it has declined 9.1%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.1660 per EA |
|---|---|
| All-time high | $0.2064 (Mar 15, 2017) |
| All-time low | $0.1596 (Jul 18, 2018) |
| Median price | $0.1753 |
| Average price | $0.1787 |
| Largest weekly change | -12.6% (Nov 22, 2017) |
| Weeks tracked | 159 |
| Tracking since | Nov 23, 2016 |
1W
N/A
1M
N/A
3M
N/A
6M
N/A
1Y
N/A
3Y
N/A
5Y
N/A
All
-9.1%
Last surveyed Dec 4, 2019 — this NDC no longer appears in the current weekly NADAC file.
Generic Alternatives
The matcher finds 7 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 59% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Dr. Reddy's Laboratories Inc. manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
bupropion hydrochloride market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Aminoketone class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of BUPROPION HCL SR 100 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for BUPROPION HCL SR 100 MG TABLET, manufactured by Dr. Reddy's Laboratories Inc., is $0.1660 per EA (NDC 43598053601), effective Dec 4, 2019.
How has the price of BUPROPION HCL SR 100 MG TABLET changed over time?
Over the history we have for it, the NADAC for BUPROPION HCL SR 100 MG TABLET has declined 9.1%. It has been tracked across 159 weekly CMS publications since Nov 23, 2016.
What are the highest and lowest recorded NADAC prices for BUPROPION HCL SR 100 MG TABLET?
Since Nov 23, 2016, the NADAC for BUPROPION HCL SR 100 MG TABLET has ranged from a low of $0.1596 (Jul 18, 2018) to a high of $0.2064 (Mar 15, 2017), with a median of $0.1753 per EA.
Are there cheaper alternatives to BUPROPION HCL SR 100 MG TABLET?
Yes. 7 manufacturers publish a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, BUPROPION HCL SR 100 MG TABLET, is $0.0679 per EA — about 59% below BUPROPION HCL SR 100 MG TABLET.
Who manufactures BUPROPION HCL SR 100 MG TABLET?
BUPROPION HCL SR 100 MG TABLET (NDC 43598053601) is labeled by Dr. Reddy's Laboratories Inc., and CMS classifies it as a generic product.